| |
| |
|
| Insider
Information: |
Saad Mark E |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
162,182 |
|
|
Indirect Shares
|
100 |
|
|
| Direct
Value |
$779,660 |
|
|
|
Indirect Value
|
$7,419 |
|
|
| Total
Shares |
162,282 |
|
|
| Total
Value |
$787,079 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 40.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Plus Therapeutics Inc |
PSTV |
Chief Financial Officer |
2013-01-31 |
138,430 |
2004-11-18 |
0 |
Premium* |
|
|
Axsome Therapeutics, Inc. |
AXSM |
Director |
2021-11-17 |
10,002 |
2021-11-17 |
100 |
Premium* |
|
|
Ra Medical Systems, Inc. |
RMED |
Director |
2021-01-05 |
13,750 |
2018-10-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2021-11-17 |
4 |
B |
$34.40 |
$10,325 |
I/I |
300 |
100 |
2.1 |
% |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2021-11-17 |
4 |
B |
$34.53 |
$103,597 |
D/D |
3,000 |
10,002 |
2.39 |
% |
|
| RMED |
Ra Medical Systems, Inc. |
Director |
– • – |
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,227 |
13,750 |
0 |
- |
|
| RMED |
Ra Medical Systems, Inc. |
Director |
– • – |
2020-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
138,085 |
0 |
- |
|
| RMED |
Ra Medical Systems, Inc. |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
29,850 |
38,085 |
0 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2019-05-23 |
4 |
B |
$22.33 |
$78,155 |
D/D |
3,500 |
7,002 |
2.39 |
- |
|
| RMED |
Ra Medical Systems, Inc. |
Director |
– • – |
2018-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,235 |
8,235 |
0 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2015-11-24 |
4 |
OE |
$5.94 |
$20,802 |
D/D |
3,502 |
3,502 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2013-01-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,070) |
138,430 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2012-03-14 |
4 |
B |
$2.54 |
$25,494 |
D/D |
10,000 |
152,500 |
2.74 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2012-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
53,500 |
142,500 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2012-01-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(33,500) |
89,000 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2011-08-12 |
4 |
B |
$3.10 |
$20,290 |
D/D |
6,500 |
122,500 |
2.74 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2011-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
33,500 |
116,000 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2010-05-21 |
4 |
B |
$4.28 |
$25,741 |
D/D |
6,000 |
82,500 |
2.74 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-08-12 |
4 |
B |
$6.63 |
$100,310 |
D/D |
15,000 |
76,500 |
2.74 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-09-05 |
4 |
B |
$5.06 |
$9,393 |
D/D |
1,850 |
61,500 |
2.74 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-09-01 |
4 |
B |
$5.20 |
$8,229 |
D/D |
1,550 |
59,650 |
2.74 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-08-31 |
4 |
B |
$5.45 |
$4,113 |
D/D |
750 |
58,100 |
2.66 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-08-30 |
4 |
B |
$5.40 |
$4,068 |
D/D |
750 |
57,350 |
2.66 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-08-29 |
4 |
B |
$5.16 |
$4,169 |
D/D |
800 |
56,600 |
2.66 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-08-28 |
4 |
B |
$5.20 |
$4,158 |
D/D |
800 |
55,800 |
2.66 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-08-25 |
4 |
B |
$4.98 |
$3,994 |
D/D |
800 |
55,000 |
2.66 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-08-24 |
4 |
B |
$4.59 |
$3,925 |
D/D |
850 |
54,200 |
2.66 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Chief Financial Officer |
• – – |
2006-08-23 |
4 |
B |
$4.28 |
$3,638 |
D/D |
850 |
53,350 |
2.66 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
